Yay for Pfizer!! They are right in our backyard! We are hopeful for their successful development for a potential treatment for SMA.
“Pfizer to Develop Families of SMA Quinazoline Drug Program.
Repligen Corporation announced January 3, 2013 that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. to advance Repligen’s SMA program, originally in-licensed from